DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Kumar S, Jacobus SJ, Cohen AD. et al.
Carfilzomib, lenalidomide, and dexamethasone (KRd) versus bortezomib, lenalidomide, and dexamethasone (VRd) for initial therapy of newly diagnosed multiple myeloma (NDMM): results of ENDURANCE (E1A11) phase III trial.
J Clin Oncol 2020;
38 (18) 3
Access:
We do not assume any responsibility for the contents of the web pages of other providers.